Mainz Biomed N.v.

Quantum Cyber (f/k/a Mainz Biomed) Announces Stock Ticker Symbol Change to NASDAQ: QUCY

Mainz Biomed Announces Appointment of Robert Liscouski as Chairman of the Board of Directors

Mainz Biomed Announces 6.0 USD Million Private Placement and Strategic Update

Mainz Biomed to Present Results of Pancreatic Cancer Verification Study at AACR 2026 Annual Meeting

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America